Genelux (GNLX) Non Operating Income (2022 - 2026)
Genelux's (GNLX) quarterly Non Operating Income came in at $243000.0 in Q1 2026, down 25.0% year-on-year from $324000.0 in Q1 2025, and up 47.27% quarter-over-quarter from $165000.0 in Q4 2025.
Genelux (GNLX) Non Operating Income (2022 - 2026) Analysis & Trends
Genelux's Non Operating Income history runs 5 years deep, the most recent figure standing at $243000.0 for Q1 2026.
- On a quarterly basis, Non Operating Income fell 25.0% year-over-year to $243000.0 in Q1 2026; TTM through Mar 2026 was $988000.0, a 47.61% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 41.49% from the prior year.
- Non Operating Income improved to $243000.0 in Q1 2026 per GNLX's latest filing, from $165000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $772000.0 in Q4 2024 and bottomed at -$3.9 million in Q1 2023.
- The 5-year median for Non Operating Income is $243000.0 (2026), against an average of -$115266.7.
- Across the five-year window, Non Operating Income soared 1347.37% in 2024 and plunged 78.63% in 2025, its largest moves.
- Year by year, Non Operating Income stood at -$401000.0 in 2022, then soared by 158.35% to $234000.0 in 2023, then surged by 229.91% to $772000.0 in 2024, then plunged by 78.63% to $165000.0 in 2025, then jumped by 47.27% to $243000.0 in 2026.
- Per Business Quant, the three latest GNLX Non Operating Income figures stand at $243000.0 (Q1 2026), $165000.0 (Q4 2025), and $244000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -8.59 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243,000.00 |
| Dec 31, 2025 | 165,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Jun 30, 2025 | 336,000.00 |
| Mar 31, 2025 | 324,000.00 |
| Dec 31, 2024 | 772,000.00 |
| Sep 30, 2024 | 474,000.00 |
| Jun 30, 2024 | 316,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 234,000.00 |
| Sep 30, 2023 | -38,000.00 |
| Jun 30, 2023 | -426,000.00 |
| Mar 31, 2023 | -3.90 Mn |
| Dec 31, 2022 | -401,000.00 |
| Sep 30, 2022 | -335,000.00 |